nach oben

Erschienen in:

02.01.2020 | Original Article

Vitamin D3 might improve headache characteristics and protect against inflammation in migraine: a randomized clinical trial

verfasst von: Zeinab Ghorbani, Mansoureh Togha, Pegah Rafiee, Zeynab Sadat Ahmadi, Reyhaneh Rasekh Magham, Mahmoud Djalali, Sahar Shahemi, Fahimeh Martami, Mahnaz Zareei, Soodeh Razeghi Jahromi, Shadi Ariyanfar, Maryam Mahmoudi

Erschienen in: Neurological Sciences | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Due to anti-inflammatory effects of vitamin D3, we aimed to explore the effects of supplementation with this vitamin on headache characteristics and serum levels of pro/anti-inflammatory markers in migraineurs.

Methods and materials

This placebo-controlled, double-blind study included 80 episodic migraineurs who randomly assigned into two equal groups to receive either daily dose of vitamin D3 2000 IU (50 μg) or placebo for 12 weeks. At baseline and after the trial, headache characteristics were determined using diaries and serum levels of interleukin (IL)-10, IL-6, inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (Cox-2) were assessed via ELISA method.

Results

At the end of trial, analysis of covariance (ANCOVA) adjusted for baseline values, and confounders revealed that vitamin D3 supplemented group experienced significantly lower headache days per month (4.71), reduced attacks duration (12.99 h/attack), less severe headaches (5.47, visual analog scale), and lower analgesics use/month (2.85) than placebo group (6.43, 18.32, 6.38 and 4.87, respectively) (P values < 0.05). Using ANCOVA adjusted for baseline levels and confounding variables, it was found that serum levels of IL-10 and Cox-2 did not significantly differ between groups after the experiment; whereas, iNOS serum level was significantly reduced in the intervention group (106.06 U/L) comparing to the controls (156.18 U/L P : 0.001). Also, the patients receiving vitamin D3 yielded a marginally significant lower IL-6 serum concentration (76.43 ng/L) compared to placebo (93.10 ng/L) (P value:0.055).

Conclusion

Based on the results of this study, we found that 2000 IU (50 μg)/day vitamin D3 supplementation for 12 weeks could improve headache characteristics and might reduce neuro-inflammation in episodic migraine.

Steiner TJ, Stovner LJ, Vos T, Jensen R, Katsarava Z (2018) Migraine is first cause of disability in under 50s: will health politicians now take notice? J Headache Pain 19(1):17PubMedPubMedCentralCrossRef

Stovner L, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A et al (2007) The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27(3):193–210PubMedCrossRef

Vetvik KG, MacGregor EA (2017) Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. Lancet Neurol 16(1):76–87PubMedCrossRef

Headache Classification Committee of the International Headache Society (IHS) (2018) The International Classification of Headache Disorders, 3rd edition. Cephalalgia : an international journal of headache 38(1):1–211

Dodick DW (2018) A phase-by-phase review of migraine pathophysiology. Headache 58(Suppl 1):4–16PubMedCrossRef

Waeber C, Moskowitz MA (2005) Migraine as an inflammatory disorder. Neurology 64(10 suppl 2):S9–S15PubMedCrossRef

Peroutka SJ (2005) Neurogenic inflammation and migraine: implications for the therapeutics. Mol Interv 5(5):304–311PubMedCrossRef

Bruno P, Carpino F, Carpino G, Zicari A (2007) An overview on immune system and migraine. Eur Rev Med Pharmacol Sci 11(4):245–248PubMed

Ramachandran R (2018) Neurogenic inflammation and its role in migraine. Semin Immunopathol 40(3):301–314PubMedCrossRef

10.

Pietrobon D (2005) Migraine: new molecular mechanisms. Neuroscientist 11(4):373–386

11.

Ceylan M, Bayraktutan OF, Becel S, Atis O, Yalcin A, Kotan D (2016) Serum levels of pentraxin-3 and other inflammatory biomarkers in migraine: association with migraine characteristics. Cephalalgia 36(6):518–525PubMedCrossRef

12.

Palm-Meinders IH, Koppen H, Terwindt GM, Launer LJ, Konishi J, Moonen JM, Bakkers JT, Hofman PA, van Lew B, Middelkoop HA, van Buchem M, Ferrari MD, Kruit MC (2012) Structural brain changes in migraine. Jama 308(18):1889–1897PubMedPubMedCentralCrossRef

13.

Sadeghi O, Nasiri M, Maghsoudi Z, Pahlavani N, Rezaie M, Askari G (2015) Effects of pyridoxine supplementation on severity, frequency and duration of migraine attacks in migraine patients with aura: a double-blind randomized clinical trial study in Iran. Iran J Neurol 14(2):74–80PubMedPubMedCentral

14.

Eren Y, Dirik E, Neselioglu S, Erel O (2015) Oxidative stress and decreased thiol level in patients with migraine: cross-sectional study. Acta Neurol Belg 115(4):643–649PubMedCrossRef

15.

Ghorbani Z, Togha M, Rafiee P, Ahmadi ZS, Rasekh Magham R, Haghighi S, et al (2019) Vitamin D in migraine headache: a comprehensive review on literature. Neurol Sci

16.

Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM, Endocrine Society (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930PubMedCrossRef

17.

Anjum I, Jaffery SS, Fayyaz M, Samoo Z, Anjum S (2018) The Role of Vitamin D in Brain Health: A Mini Literature Review. Cureus 10(7):e2960-e

18.

van Harten-Gerritsen AS, Balvers MG, Witkamp RF, Kampman E, van Duijnhoven FJ (2015) Vitamin D, Inflammation, and colorectal Cancer progression: a review of mechanistic studies and future directions for epidemiological studies. Cancer Epidemiol Biomark Prev 24(12):1820–1828CrossRef

19.

Helde-Frankling M, Bjorkhem-Bergman L (2017) Vitamin D in Pain Management. Int J Mol Sci 18(10):2170PubMedCentralCrossRef

20.

Martin KR, Reid DM (2017) Is there role for vitamin D in the treatment of chronic pain? Ther Adv Musculoskelet Dis 9(6):131–135PubMedPubMedCentralCrossRef

21.

Togha M, Razeghi Jahromi S, Ghorbani Z, Martami F, Seifishahpar M (2018) Serum vitamin D status in a Group of Migraine Patients Compared with Healthy Controls: a case-control study. Headache 58(10):1530–1540PubMedCrossRef

22.

Martami F, Razeghi Jahromi S, Togha M, Ghorbani Z, Seifishahpar M, Saidpour A (2018) The serum level of inflammatory markers in chronic and episodic migraine: a case-control study. Neurol Sci 39(10):1741–1749PubMedCrossRef

23.

Sarchielli P, Alberti A, Baldi A, Coppola F, Rossi C, Pierguidi L et al (2006) Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache: J Head Face Pain 46(2):200–207CrossRef

24.

Fidan I, Yuksel S, Ymir T, Irkec C, Aksakal FN (2006) The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine. J Neuroimmunol 171(1–2):184–188PubMedCrossRef

25.

Tietjen G, Khubchandani J, Khan A, Herial N (2010) Adiponectin and Inflammatory Cytokines in Young Women with Migraine

26.

Yücel M, Kotan D, Çiftçi GG, Çiftçi I, Cikriklar H (2016) Serum levels of endocan, claudin-5 and cytokines in migraine. Eur Rev Med Pharmacol Sci 20(5):930–936PubMed

27.

Uzar E, Evliyaoglu O, Yucel Y, Ugur Cevik M, Acar A, Guzel I et al (2011) Serum cytokine and pro-brain natriuretic peptide (BNP) levels in patients with migraine. Eur Rev Med Pharmacol Sci 15(10):1111–1116PubMed

28.

Oliveira AB, Bachi ALL, Ribeiro RT, Mello MT, Tufik S, Peres MFP (2017) Unbalanced plasma TNF-α and IL-12/IL-10 profile in women with migraine is associated with psychological and physiological outcomes. J Neuroimmunol 313:138–144PubMedCrossRef

29.

Jahromi SR, Abolhasani M, Ghorbani Z, Sadre-Jahani S, Alizadeh Z, Talebpour M et al (2017) Bariatric surgery promising in migraine control: a controlled trial on weight loss and its effect on migraine headache. Obes Surg:1–10

30.

Mottaghi T, Askari G, Khorvash F, Maracy MR (2015) Effect of vitamin D supplementation on symptoms and C-reactive protein in migraine patients. J Res Med Sci 20(5):477–482PubMedPubMedCentralCrossRef

31.

Gazerani P, Fuglsang R, Pedersen JG, Sorensen J, Kjeldsen JL, Yassin H et al (2019) A randomized, double-blinded, placebo-controlled, parallel trial of vitamin D3 supplementation in adult patients with migraine. Curr Med Res Opin 35(4):715–723PubMedCrossRef

32.

Buettner C, Nir RR, Bertisch SM, Bernstein C, Schain A, Mittleman MA et al (2015) Simvastatin and vitamin D for migraine prevention: a randomized, controlled trial. Ann Neurol 78(6):970–981PubMedPubMedCentralCrossRef

33.

Wang M (2013) Cortical spreading depression and calcitonin gene-related peptide: a brief review of current progress. Neuropeptides 47(6):463–466PubMedCrossRef

34.

Close LN, Eftekhari S, Wang M, Charles AC, Russo AFJC (2018) Cortical spreading depression as a site of origin for migraine: Role of CGRP 0333102418774299

35.

(2015) Pathophysiology of Headaches From Molecule to Man. Paolo Martelletti RJ (ed). Springer, Cham

36.

Vanmolkot F, De Hoon J (2007) Increased C-reactive protein in young adult patients with migraine. Cephalalgia 27(7):843–846PubMedCrossRef

37.

Kurth T, Ridker P, Buring J (2008) Migraine and biomarkers of cardiovascular disease in women. Cephalalgia 28(1):49–56PubMedCrossRef

38.

Hamed SA, Hamed EA, Eldin AME, Mahmoud NM (2010) Vascular risk factors, endothelial function, and carotid thickness in patients with migraine: relationship to atherosclerosis. J Stroke Cerebrovasc Dis 19(2):92–103PubMedCrossRef

39.

Tietjen GE, Khubchandani J (2015) Vascular biomarkers in migraine. Cephalalgia 35(2):95–117PubMedCrossRef

40.

Güzel I, Taşdemir N, Çelik Y (2013) Evaluation of serum transforming growth factor β1 and C-reactive protein levels in migraine patients. Neurol Neurochir Pol 47(4):357–362PubMedCrossRef

41.

Covelli V, Munno I, Pellegrino N, Altamura M, Decandia P, Marcuccio C, di Venere A, Jirillo E (1991) Are TNF-alpha and IL-1 beta relevant in the pathogenesis of migraine without aura? Acta Neurol 13(2):205–211

42.

Perini F, D'andrea G, Galloni E, Pignatelli F, Billo G, Alba S et al (2005) Plasma cytokine levels in migraineurs and controls. Headache: J Head Face Pain 45(7):926–931CrossRef

43.

Malhotra R (2016) Understanding migraine: potential role of neurogenic inflammation. Ann Indian Acad Neurol 19(2):175–182PubMedPubMedCentralCrossRef

44.

Olesen J (2008) The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Pharmacol Ther 120(2):157–171PubMedCrossRef

45.

Al-Daghri NM, Bukhari I, Yakout SM, Sabico S, Khattak MNK, Aziz I et al (2018) Associations of serum nitric oxide with vitamin D and other metabolic factors in apparently healthy adolescents. Biomed Res Int 2018:1489132PubMedPubMedCentralCrossRef

46.

Golden TN (2016) The role of inducible nitric oxide synthase in macrophage activation following acute lung injury

47.

de Oliveira DL, Hirotsu C, Tufik S, Andersen ML (2017) The interfaces between vitamin D, sleep and pain. J Endocrinol 234(1):R23–R36PubMedCrossRef

48.

Linden J, Granasen G, Salzer J, Svenningsson A, Sundstrom P (2019) Inflammatory activity and vitamin D levels in an MS population treated with rituximab. Mult Scler J Exp Transl Clin 5(1):2055217319826598PubMedPubMedCentral

49.

Wang Y, Yang S, Zhou Q, Zhang H, Yi B (2019) Effects of vitamin D supplementation on renal function, inflammation and glycemic control in patients with diabetic nephropathy: a systematic review and meta-analysis. Kidney Blood Press Res 44(1):72–87PubMedCrossRef

50.

Filgueiras MS, Rocha NP, Novaes JF, Bressan J (2018) Vitamin D status, oxidative stress, and inflammation in children and adolescents: a systematic review. Crit Rev Food Sci Nutr 1–10

51.

Chen N, Wan Z, Han SF, Li BY, Zhang ZL, Qin LQ (2014) Effect of vitamin D supplementation on the level of circulating high-sensitivity C-reactive protein: a meta-analysis of randomized controlled trials. Nutrients 6(6):2206–2216PubMedPubMedCentralCrossRef

52.

Sepidarkish M, Farsi F, Akbari-Fakhrabadi M, Namazi N, Almasi-Hashiani A, Maleki Hagiagha A, Heshmati J (2019) The effect of vitamin D supplementation on oxidative stress parameters: a systematic review and meta-analysis of clinical trials. Pharmacol Res 139:141–152PubMedCrossRef

53.

Akbari M, Ostadmohammadi V, Lankarani KB, Tabrizi R, Kolahdooz F, Heydari ST et al (2018) The effects of vitamin D supplementation on biomarkers of inflammation and oxidative stress among women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Horm Metab Res 50(4):271–279PubMedCrossRef

54.

Colotta F, Jansson B, Bonelli F (2017) Modulation of inflammatory and immune responses by vitamin D. J Autoimmun 85:78–97PubMedCrossRef

55.

Sarchielli P, Floridi A, Mancini M, Rossi C, Coppola F, Baldi A, Pini LA, Calabresi P (2006) NF-κB activity and iNOS expression in monocytes from internal jugular blood of migraine without Aura patients during attacks. Cephalalgia 26(9):1071–1079PubMedCrossRef

56.

Dursun E, Gezen-Ak D, Yilmazer S (2014) The influence of vitamin D treatment on the inducible nitric oxide synthase (INOS) expression in primary hippocampal neurons. Noro Psikiyatri Arsivi 51(2):163–168PubMedPubMedCentralCrossRef

57.

Shipton EA, Shipton EE (2015) Vitamin D and Pain: Vitamin D and Its Role in the Aetiology and Maintenance of Chronic Pain States and Associated Comorbidities. Pain Res Treat 2015:904967PubMedPubMedCentral

58.

Pradhan AA, Bertels Z, Akerman S (2018) Targeted nitric oxide synthase inhibitors for migraine. Neurotherapeutics 15(2):391–401PubMedPubMedCentralCrossRef

59.

Andrukhova O, Slavic S, Zeitz U, Riesen SC, Heppelmann MS, Ambrisko TD et al (2014) Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice. Mol Endocrinol (Baltimore, Md) 28(1):53–64CrossRef

60.

Bikle D (2009) Nonclassic actions of vitamin D. J Clin Endocrinol Metab 94(1):26–34PubMedCrossRef

Titel: Vitamin D3 might improve headache characteristics and protect against inflammation in migraine: a randomized clinical trial
verfasst von: Zeinab Ghorbani
Mansoureh Togha
Pegah Rafiee
Zeynab Sadat Ahmadi
Reyhaneh Rasekh Magham
Mahmoud Djalali
Sahar Shahemi
Fahimeh Martami
Mahnaz Zareei
Soodeh Razeghi Jahromi
Shadi Ariyanfar
Maryam Mahmoudi
Publikationsdatum: 02.01.2020
Verlag: Springer International Publishing
Erschienen in: Neurological Sciences / Ausgabe 5/2020
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-019-04220-8

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Introduction

Methods and materials

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2020

Relaxation therapy as a treatment for tics in patients with Tourette syndrome: a systematic literature review

Biochemical parameters in determination of nutritional status in amyotrophic lateral sclerosis

Freezing of gait in Parkinson’s disease may share the mechanisms of dystonia

A subjective cognitive impairments scale for migraine attacks: validation of the Italian version of the MIG-SCOG

First Portuguese patient presenting with hereditary sensory and autonomic neuropathy type 1E associated with a novel mutation in DNMT1 gene